Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCQS Natural Resources Growth & Income Regulatory News (CYN)

Share Price Information for CQS Natural Resources Growth & Income (CYN)

Share Price is delayed by 15 minutes
Get Live Data
340.00    -7.00 (-2.02%)
Bid:
340.00
Ask:
345.00
Spread: 5.00 (1.471%)
Market Cap: £123.47m
CYN Live PriceLast checked at - London Stock Exchange

Intraday CQS Natural Resources Growth & Income Share Chart

Tender Price

30 Sep 2025 07:00

RNS Number : 3044B
CQS Natural Resources Grwth&Inc PLC
30 September 2025
 

30 September 2025

 

CQS Natural Resources Growth and Income PLC(the "Company")LEI: 549300ES8CNIK2CQR054

Tender Price

 

Further to the announcement of 1 July 2025, the Board is pleased to confirm that the assets within the Tender Pool have been fully realised for cash. The Tender Pool Determination Date was 29 September 2025 and, as at that date, the Tender Pool Final Asset Value was £61,112,800, resulting in a Tender Price of 208.33 pence per Tender Exit Share.

During the course of the realisation of the Tender Pool, the proceeds of portfolio sales were held in a short-dated UK government bond and cash.

Cavendish will purchase, as principal, the 29,334,059 Shares validly tendered under the Tender Offer at the Tender Price. Following completion of those purchases, Cavendish will then sell all the Tender Exit Shares back to the Company at the Tender Price pursuant to the Repurchase Agreement by way of an on-market transaction on the main market for listed securities of the London Stock Exchange.

The Company will keep 8,800,000 Shares bought back in treasury with the remainder to be cancelled.

The repurchase of Tender Exit Shares by the Company under the Repurchase Agreement will be funded from the Tender Pool and deducted from the Company's distributable reserves.

It is expected that payments in respect of Tender Exit Shares held in uncertificated form will be made in CREST on 7 October 2025 and that cheques will be dispatched on 14 October 2025 in respect of Tender Exit Shares held in certificated form.

Following the repurchase of the Tender Exit Shares, the Company's issued ordinary share capital will comprise 46,354,450 ordinary shares of 25p each, of which 11,405,671 (equivalent to 24.61%) are held in Treasury. The number of ordinary shares to be used in the calculation of voting rights is now 34,948,779.

Defined terms used in this announcement shall, unless the context requires otherwise, have the meanings ascribed to them in the circular to Shareholders published by the Company on 28 May 2025.

 

For further information, please contact:

CQS Natural Resources Growth and Income PLC

Christopher Casey, Chairman

cnr@tavistock.co.uk

(c/o Tavistock Communications)

 

Cavendish, Financial Adviser and Corporate Broker

Robert Peel, Andrew Worne

+44 20 7908 6000

 

Frostrow Capital LLP, Company Secretary

Tasmin Arthurton

+44 203 709 2408

cosec@frostrow.com

 

Tavistock, Public Relations

Jos Simson, Gareth Tredway, Tara Vivian-Neal

+44 20 7920 3150

cnr@tavistock.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEDZGZLLLKGKZM
Date   Source Headline
11th Dec 202410:06 amRNSDirector/PDMR Shareholding
10th Dec 20244:31 pmRNSBoard Changes and Result of AGM
10th Dec 20241:34 pmRNSNet Asset Value(s)
9th Dec 20241:41 pmRNSNet Asset Value(s)
6th Dec 20242:19 pmRNSNet Asset Value(s)
6th Dec 20249:25 amRNSHolding(s) in Company
5th Dec 20242:53 pmRNSHolding(s) in Company
5th Dec 20241:06 pmRNSDirector/PDMR Shareholding
5th Dec 202412:16 pmRNSNet Asset Value(s)
5th Dec 202411:27 amRNSHolding(s) in Company
4th Dec 20243:29 pmRNSHolding(s) in Company
4th Dec 20242:32 pmRNSNet Asset Value(s)
4th Dec 20241:08 pmRNSHolding(s) in Company
3rd Dec 202411:50 amRNSNet Asset Value(s)
2nd Dec 20245:32 pmRNSHolding(s) in Company
2nd Dec 20243:13 pmRNSHolding(s) in Company
2nd Dec 20241:28 pmRNSNet Asset Value(s)
2nd Dec 20241:20 pmRNSHolding(s) in Company
2nd Dec 202411:45 amRNSTotal Voting Rights
2nd Dec 202411:41 amRNSDirector Declaration
29th Nov 20241:45 pmRNSNet Asset Value(s)
28th Nov 20241:18 pmRNSNet Asset Value(s)
28th Nov 202411:35 amRNSHolding(s) in Company
27th Nov 20244:51 pmRNSHolding(s) in Company
27th Nov 20242:19 pmRNSNet Asset Value(s)
27th Nov 20249:19 amRNSHolding(s) in Company
26th Nov 202412:54 pmRNSNet Asset Value(s)
26th Nov 202410:55 amRNSHolding(s) in Company
25th Nov 20241:18 pmRNSNet Asset Value(s)
22nd Nov 20243:07 pmRNSNet Asset Value(s)
21st Nov 20242:05 pmRNSNet Asset Value(s)
21st Nov 20249:21 amRNSMonthly Fact Sheet as at 31 October 2024
20th Nov 202412:52 pmRNSNet Asset Value(s)
19th Nov 202412:44 pmRNSNet Asset Value(s)
19th Nov 20247:00 amRNSPresentation via Investor Meet Company
18th Nov 202412:49 pmRNSNet Asset Value(s)
15th Nov 20241:54 pmRNSNet Asset Value(s)
14th Nov 20242:41 pmRNSNet Asset Value(s)
14th Nov 20241:55 pmRNSHolding(s) in Company
13th Nov 202412:52 pmRNSNet Asset Value(s)
12th Nov 20245:03 pmRNSHolding(s) in Company
12th Nov 202412:13 pmRNSNet Asset Value(s)
11th Nov 202412:58 pmRNSNet Asset Value(s)
8th Nov 20243:13 pmRNSNet Asset Value(s)
7th Nov 202412:38 pmRNSNet Asset Value(s)
6th Nov 20243:26 pmRNSHolding(s) in Company
6th Nov 202412:56 pmRNSNet Asset Value(s)
5th Nov 20243:31 pmRNSHolding(s) in Company
5th Nov 20242:54 pmRNSNet Asset Value(s)
4th Nov 20243:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.